Salute e Benessere

EADV Congress 2024: New research confirms link between perceived stress and…

In the study, psoriatic lesions were induced in healthy human skin xenografts on mice (n=25) through the injection of autologous, in vitro IL-2-preactivated peripheral blood mononuclear cells. After achieving lesion remission with topical dexamethasone, the mice were exposed to either sonic (sound) or sham stress for 24 hours. The recurrence of psoriatic lesions was then tracked over the following 14 days. In the study, psoriatic lesions were induced in healthy human skin xenografts on mice...
PR Newswire
27/09/2024

Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6%…

Key Takeaways from the Hormone Replacement Therapy Market Report Key Takeaways from the Hormone Replacement Therapy Market Report To read more about the latest highlights related to the hormone replacement therapy market, get a snapshot of the key highlights entailed in theGlobal Hormone Replacement Therapy Market Report Hormone Replacement Therapy Overview Hormone replacement therapy (HRT) is a medical treatment commonly used to alleviate symptoms associated with menopause,...
PR Newswire
26/09/2024

Grant of Restricted Stock Units and Warrants to Employees in Genmab

Company Announcement COPENHAGEN, Denmark; September 26, 2024 –Genmab A/S(Nasdaq: GMAB) announced today that the Board decided to grant 23,954 restricted stock units and 13,915 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a conditional right to receive one share in Genmab A/S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market price on the...
Nasdaq GlobeNewswire
26/09/2024

AI in Life Sciences Market Poised for Explosive Growth with 27.9% CAGR Through…

The global artificial intelligence (AI) in the life sciences market is witnessing significant growth, driven by advancements in AI technologies and their increasing adoption across the life sciences sector. This report provides a comprehensive analysis of the market size, estimating both current and historical revenues segmented by products, applications, end users, and regions. By examining these factors, the report offers insights into the evolving landscape of AI in life sciences…
PR Newswire
26/09/2024

Global Theranostics Market to Triple, Reaching $12.7 Billion by 2029

The theranostics market is robust and dynamic, characterized by a diverse array of companies offering comprehensive solutions. Major players in the market, including leaders in diagnostics and therapeutics, are profiled extensively, detailing their revenues, product portfolios, and recent strategic initiatives. The competitive landscape is thoroughly examined alongside market trends and key dynamics such as drivers, restraints, and opportunities. Segmented by product type, theranostics offerings…
PR Newswire
26/09/2024

LiveWell Awarded Frost & Sullivan's 2024 Global Customer Value Leadership Award…

In their report, Frost & Sullivan state that LiveWell provides world-class digital health and well-being solutions to balance physical, mental, social, and financial health through its user-friendly app. LiveWell offers a wide range of tools that include mood and stress tracking; mental health support; and services offering support on a range of wellness topics. LiveWell is one of many pioneers addressing significant challenges to the mental and behavioral health industry, such as stigma…
PR Newswire
26/09/2024

Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib…

MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clinical studies, MNV-201 demonstrated improved engraftment and bone marrow reconstitution potential of patient derived hematopoietic stem cellsIn vitro data also demonstrated improved ability to differentiate to erythroid cells, supporting potential for improvement in biomarkers of anemiaHAIFA, Israel, Sept.26, 2024...
Nasdaq GlobeNewswire
26/09/2024

OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate…

OSE Immunotherapeutics Announces Historic H1 2024 Results andProvides Corporate Update Financial and business highlightsTotal H1 2024 incomes of €82.5 million thanks to Company's new partnerships.New strategic partnership with AbbVie for up to $713 million, including $48 million received upon signature.Major partnership expansion with Boehringer Ingelheim: Amendment of the collaboration and licensing agreement on first-in-class SIRPα compounds developed both in...
Nasdaq GlobeNewswire
26/09/2024

Vistin Pharma ASA: Mandatory notification of trade

Saga Pure ASA has on 26 September 2024 purchased 50,000 shares in Vistin Pharma ASA at NOK 28.2 per share. After the transaction Saga Pure ASA has a holding of 700,000 shares, corresponding to 1.58% ownership.Saga Pure ASA is closely associated with board member Øystein Stray Spetalen. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment 20240926_Notification of trade_Saga i Vistin
Nasdaq GlobeNewswire
26/09/2024

Medical Gas and Equipment Market to Hit USD 26.44 Billion by 2029 with 5.8% CAGR…

Browse in-depth TOC on "Medical Gas and Equipment Market" Browse in-depth TOC on "Medical Gas and Equipment Market" 394 - Tables 60 - Figures 380 - Pages By type, the medical gas and equipment market is segmented into medical gases and medical gas equipment. In 2023, the medical gas segment accounted for the largest share in the medical gas and equipment market due to the essential role of gases in various medical applications, including anesthesia, respiratory therapy…
PR Newswire
26/09/2024

AbZelectPRO™ enables biopharma customers to reach their research cell bank in 10…

Simon Keen, VP of Cell Line Development at Abzena, states: "Our goal with AbZelectPRO™ was to offer our customers a strong cell line development platform with shorter timelines, higher production levels and lower production costs. When we launched the platform in January 2024, we were utilizing data from initial research and development projects. Over the past 10 months we've been fine-tuning the platform, generating more data from real-world projects, which has allowed us to showcase its…
PR Newswire
26/09/2024

Bavarian Nordic Upgrades its Financial Guidance for 2024

COPENHAGEN, Denmark, September 26, 2024– Bavarian Nordic A/S (OMX: BAVA) upgrades its financial guidance for 2024.Based on today's announced mpox vaccine order and additional orders secured, combined with improved performance in Travel Health, as well as other parts of the business, Bavarian Nordic now expects revenue between DKK 5,400 million and DKK 5,800 million and EBITDA between DKK 1,450 million and DKK 1,700 million.Revenue from the Travel Health business is now expected at...
Nasdaq GlobeNewswire
26/09/2024

Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines

First award under UNICEF emergency tender to secure availability of mpox vaccines for AfricaCOPENHAGEN, Denmark, September 26, 2024– Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with UNICEF for the supply of 1 million doses of the MVA-BN ®mpox vaccine for countries in Africa impacted by the mpox outbreak.Under the agreement, UNICEF will procure 1 million doses of the vaccine which includes the 500,000 doses that were committed by Gavi and announced on September...
Nasdaq GlobeNewswire
26/09/2024

Cleanroom Technologies Market to Hit USD 12.3 Billion by 2029 with 6.9% CAGR |…

Browse in-depth TOC on "Cleanroom Technologies Market" Browse in-depth TOC on "Cleanroom Technologies Market" 350 - Tables 280 - Figures 400 - Pages Based on Type, the cleanroom technologies market has been segmented into standard cleanrooms, modular cleanrooms and mobile cleanrooms. The modular cleanroom is further segmented into hardwall cleanrooms and softwall cleanrooms. The modular cleanrooms segment accounted for the largest share of the cleanroom technologies market...
PR Newswire
26/09/2024

Urteste Expands Development of Innovative Diagnostic Projects

Urteste Expands Development of Innovative Diagnostic ProjectsGdańsk, Poland – 26 SEPTEMBER 2024, 16:00 CET - Urteste S.A. (Warsaw Stock Exchange: URT), a biotechnology company specializing in the development of breakthrough technology to detect cancer from urine samples, best known for its flagship project PANURI, a diagnostic test for pancreatic cancer. The company's breakthrough technology allows for early detection of cancer by measuring the activity of enzymes present...
Nasdaq GlobeNewswire
26/09/2024

Infectious Disease Therapeutics Market Surges to USD 140.71 Billion by 2030…

Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=817164 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=817164 Browse in-depth TOC onInfectious Disease Therapeutics Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Infectious Disease Therapeutics Market Overview Market Drivers Fueling Growth in the Infectious Disease Therapeutics Market Rising Prevalence of Infectious...
PR Newswire
26/09/2024

Coronado Research announce appointment of Gail Kniveton to Chief Talent Officer…

Kniveton commented, "I am delighted to be joining an organisation that places employee needs at the top of the agenda. I have always focussed my work on businesses with high innovation, looking to change working practices and finding "unicorn people" to lead them. Coronado Research aligns perfectly with my passion for creating high performing, high innovation teams. We already have a great team lined up and I look forward to bringing them into Coronado over the coming months and…
PR Newswire
26/09/2024

ZEISS reinvents lens extraction with the first hand-held ultrasound-free lens…

"We're putting the future of lens extraction in the hands of surgeons today," says Euan S. Thomson, Ph.D., President of Ophthalmology Strategic Business Unit and Head of the Digital Business Unit for ZEISS Medical Technology. "The ZEISS MICOR 700 extends our cataract solutions portfolio and serves as a testament to ZEISS's ability to deliver revolutionary, state-of-the-art technologies that advance cataract surgery, benefiting both patients and surgeons." "We're putting…
PR Newswire
26/09/2024

Wyoming Medicaid Becomes First State to Cover Cognoa's Canvas Dx, Expanding…

In Wyoming, as in many states, autism remains under-detected. The average age of diagnosis is 6.1 years – over a year later than the U.S. average of 5 years, and more than 4.5 years after a reliable diagnosis is generally possible, at 18 months. Families in Wyoming travel up to 224 miles for an autism evaluation, creating additional barriers to timely diagnosis and intervention and underscoring the scarcity of services. InWyoming, as in many states, autism remains under-detected. The average...
PR Newswire
26/09/2024

Global Health Exhibition to Showcase Unique Advances in AI-Enabled Diagnostics…

"We are in a transformative era in radiology, where artificial intelligence and now Gen AI is redefining the entire patient experience, from enhancing diagnostic accuracy to improving safety. This paradigm shift in healthcare allows for personalised and more precise treatment options," said Global Health Exhibition panellist Dr. Maha Gmira, Chief Technology Officer of SolutionAI. "We are in a transformative era in radiology, where artificial intelligence and now Gen AI is…
PR Newswire
26/09/2024

SciBase expands to new market in Pennsylvania and receives first order from…

"We are thrilled to commence a partnership with Seraly Dermatology Their focus on individual patient care is one of many reasons we are proud to partner with them. I'm also pleased to see that our recent U.S. team expansion is already having a positive impact on the U.S. market by increasing access of the Nevisense test to more patients in new geographic areas", says Pia Renaudin, CEO of SciBase. " We are thrilled to commence a partnership with Seraly Dermatology Their focus on…
PR Newswire
26/09/2024

Study Finds Lycomato® Improves Mitochondrial Function and Delays Cellular Aging

To assess the effectiveness of Lycomato in delaying cellular aging, researchers treated cells with rotenone, a compound that triggers mitochondrial dysfunction. Results showed that when cells were also pre-treated with Lycomato, mitochondrial function improved, mitochondrial ROS levels were reduced by about 70%, ATP levels restored to around 70% and the number of senescent cells was dramatically reduced to near-normal levels. Together, results suggest Lycomato and similar phytonutrient-rich…
PR Newswire
26/09/2024

Sultan bin Ahmed launches Small Hearts and Eyes Campaign at the National…

Sultan bin Ahmedlistened to a detailed explanation from Dr.Ahmed Mohammed Al Kamali, a pediatric heart surgery specialist, about the cases that have undergone surgery, as well as those that will be examined and diagnosed to determine the appropriate type of treatment, whether through catheterization or heart surgery for the sick children. The Chairman of the Sharjah Media Council, learned about the procedures followed in diagnosing medical cases and determining the treatment...
PR Newswire
26/09/2024

Evaxion significantly expands vaccine development collaboration with MSD

Agreement provides MSD with options to license Evaxion's preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3Evaxion will host a conference call and webcast to discuss the agreement on September 27, 2024COPENHAGEN, Denmark, Sept.26, 2024(GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that it has entered into an option and license agreement with...
Nasdaq GlobeNewswire
26/09/2024
Altri  Comunicati